Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
XILIO THERAPEUTICS, INC.
About XLO
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing masked immuno-oncology, or I-O, therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. Its pipeline products include Vilastobart, Efarindodekin alfa, XTX501, and masked T cell engagers. Vilastobart is an investigational masked, Fc-enhanced anti-CTLA-4 designed to block CTLA-4 and deplete regulatory T cells when activated (unmasked) in the tumor microenvironment (TME). XTX501 is a novel bispecific PD-1 / masked IL-2 designed to selectively stimulate PD-1 positive, antigen-experienced T cells and enhance their function. Its masked T cell engager programs consist of PSMA and STEAP1 with co-stimulation and CLDN18.2. The masked T cell engagers include molecules with one or more tumor-associated antigen (TAA) binding domains and a CD3 targeting domain.
Find out what a historical investment in XILIO THERAPEUTICS, INC. would be worth today using our XLO stock calculator.
Market Capitalisation
$50.02M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
36.94K
High today
$8.81
Low today
$8.34
Open price
$8.80
52-week high
$16.10
52-week low
$6.47
Ready to start your investing journey with Stake?
Open an accountHow do I buy XLO shares in Australia?
Buying XLO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in XILIO THERAPEUTICS, INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in XLO
What is the ticker symbol of XILIO THERAPEUTICS, INC.?
The ticker symbol for XILIO THERAPEUTICS, INC. is XLO.
How much is one share of XLO?
One share of XLO is valued at $8.35 as of 16 May 2026.
What is the market capitalisation of XILIO THERAPEUTICS, INC. XLO?
As of 16 May 2026 XILIO THERAPEUTICS, INC. has a market cap of $50.02M.
What is the 52-week high for XILIO THERAPEUTICS, INC. stock?
The XILIO THERAPEUTICS, INC. 52-week high stock price is $16.10.
What is the 52-week low for XILIO THERAPEUTICS, INC. stock?
The XILIO THERAPEUTICS, INC. 52-week low stock price is $6.47.
Can I buy XLO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy XLO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in XLO on Stake
- Buy XLO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of XLO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
XLO related stocks